John A. Ward

Array ( [id] => 4079988 [patent_doc_number] => 06054298 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'Fringe proteins and pattern formation' [patent_app_type] => 1 [patent_app_number] => 8/586165 [patent_app_country] => US [patent_app_date] => 1996-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 7 [patent_no_of_words] => 12639 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054298.pdf [firstpage_image] =>[orig_patent_app_number] => 586165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6544900 [patent_doc_number] => 20020137697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'CHIMERIC RECEPTOR GENES AND CELLS TRANSFORMED THEREWITH' [patent_app_type] => new [patent_app_number] => 08/547263 [patent_app_country] => US [patent_app_date] => 1995-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 16324 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137697.pdf [firstpage_image] =>[orig_patent_app_number] => 08547263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4047891 [patent_doc_number] => 05908969 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-01 [patent_title] => 'Method of detecting prions in a sample and transgenic animal used for same' [patent_app_type] => 1 [patent_app_number] => 8/521992 [patent_app_country] => US [patent_app_date] => 1995-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 25046 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/908/05908969.pdf [firstpage_image] =>[orig_patent_app_number] => 521992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4143705 [patent_doc_number] => 06060643 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Mouse model with human immune system' [patent_app_type] => 1 [patent_app_number] => 8/511396 [patent_app_country] => US [patent_app_date] => 1995-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6376 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060643.pdf [firstpage_image] =>[orig_patent_app_number] => 511396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342344 [patent_doc_number] => 06590086 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-08 [patent_title] => 'Mutants of the Rb and p53 genes and uses thereof' [patent_app_type] => B1 [patent_app_number] => 08/506436 [patent_app_country] => US [patent_app_date] => 1995-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 17 [patent_no_of_words] => 12897 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/590/06590086.pdf [firstpage_image] =>[orig_patent_app_number] => 08506436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4134532 [patent_doc_number] => 06060049 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Surrogate tolerogenesis for the development of tolerance to xenografts' [patent_app_type] => 1 [patent_app_number] => 8/295899 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22893 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060049.pdf [firstpage_image] =>[orig_patent_app_number] => 295899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6750964 [patent_doc_number] => 20030045485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'P53-MEDIATED APOPTOSIS FOR THE THERAPEUTIC TREATMENT OF DISEASES' [patent_app_type] => new [patent_app_number] => 08/463069 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 12772 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20030045485.pdf [firstpage_image] =>[orig_patent_app_number] => 08463069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3950136 [patent_doc_number] => 05935567 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-10 [patent_title] => 'Cytokine IP-10 as an anti-tumor agent' [patent_app_type] => 1 [patent_app_number] => 8/464276 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 5831 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/935/05935567.pdf [firstpage_image] =>[orig_patent_app_number] => 464276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 790360 [patent_doc_number] => 06984380 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-01-10 [patent_title] => 'Treatment of diseases involving faulty MHC class I antigen complex presentation' [patent_app_type] => utility [patent_app_number] => 08/455022 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 19 [patent_no_of_words] => 10670 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/984/06984380.pdf [firstpage_image] =>[orig_patent_app_number] => 08455022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4390645 [patent_doc_number] => 06296846 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-02 [patent_title] => 'Induced tolerance to xenografts' [patent_app_type] => 1 [patent_app_number] => 8/451210 [patent_app_country] => US [patent_app_date] => 1995-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5480 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/296/06296846.pdf [firstpage_image] =>[orig_patent_app_number] => 451210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3936345 [patent_doc_number] => 05981273 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Composition comprising an endosomolytic agent for introducing nucleic acid complexes into higher eucaryotic cells' [patent_app_type] => 1 [patent_app_number] => 8/450417 [patent_app_country] => US [patent_app_date] => 1995-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 65 [patent_figures_cnt] => 55 [patent_no_of_words] => 51076 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981273.pdf [firstpage_image] =>[orig_patent_app_number] => 450417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1417244 [patent_doc_number] => 06514752 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Homologous recombination for universal donor cells and chimeric mammalian hosts' [patent_app_type] => B1 [patent_app_number] => 08/443613 [patent_app_country] => US [patent_app_date] => 1995-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 20 [patent_no_of_words] => 19289 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514752.pdf [firstpage_image] =>[orig_patent_app_number] => 08443613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4194941 [patent_doc_number] => 06130364 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-10 [patent_title] => 'Production of antibodies using Cre-mediated site-specific recombination' [patent_app_type] => 1 [patent_app_number] => 8/412826 [patent_app_country] => US [patent_app_date] => 1995-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12595 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/130/06130364.pdf [firstpage_image] =>[orig_patent_app_number] => 412826 [rel_patent_id] =>[rel_patent_doc_number] =>)